SEARCH

SEARCH BY CITATION

References

  • Anglaret X, Toure S, Gourvellec G et al. (2004) Impact of vital status investigation procedures on estimates of survival in cohorts of HIV-infected patients from Sub-Saharan Africa. Journal of Acquired Immune Deficiency Syndrome 35, 320323.
  • Bisson GP, Gaolathe T, Gross R et al. (2008) Overestimates of survival after HAART: implications for global scale-up efforts. PLoS ONE 3, e1725.
  • Braitstein P, Brinkhof MW, Dabis F et al. (2006) Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 367, 817824.
  • Brinkhof MW, Dabis F, Myer L et al. (2008) Early loss of HIV-infected patients on potent antiretroviral therapy programs in lower-income countries. Bulletin of the World Health Organization 86, 559567.
  • Brinkhof MW, Pujades-Rodriguez M & Egger M (2009) Mortality of patients lost to follow-up in antiretroviral treatment programs in resource-limited settings: systematic review and meta-analysis. PLoS ONE 4, e5790.
  • Calmy A, Pinoges L, Szumilin E et al. (2006) Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort. AIDS 20, 11631169.
  • Dalal RP, Macphail C, Mqhayi M et al. (2008) Characteristics and outcomes of adult patients lost to follow-up at an antiretroviral treatment clinic in Johannesburg, South Africa. Journal of Acquired Immune Deficiency Syndrome 47, 101107.
  • Etard JF, Ndiaye I, Thierry-Mieg M et al. (2006) Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal. AIDS 20, 11811189.
  • Giordano TP, Gifford AL, White AC et al. (2007) Retention in care: a challenge to survival with HIV infection. Clinical Infectious Diseases 44, 14931499.
  • Gutierez R (2002) Parametric frailty and shared frailty survival models. The Stata Journal 2, 2244.
  • Keiding N, Andersen PK & Klein JP (1997) The role of frailty models and accelerated failure time models in describing heterogeneity due to omitted covariates. Statistics in Medicine 16, 215224.
  • Lawn SD, Harries AD, Anglaret X et al. (2008) Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS 22, 18971908.
  • Losina E, Toure H, Uhler L et al. (2008) The clinical and economic impact of interventions to prevent loss to follow-up (LTFU) in resource-limited settings. PLoS Medicine 10, e174.
  • PEPFAR (2008) U.S. President’s Emergency Plan for AIDS Relief. Available at: http://www.pepfar.gov/documents/organization/115411.pdf. (accessed on 30 September 2009)
  • Rosen S, Fox MP & Gill CJ (2007) Patient retention in antiretroviral therapy programs in sub-Saharan Africa. PLoS Medicine 4, e298.
  • Srasuebkul P, Lim PL, Lee MP et al. (2009) Short-term clinical disease progression in HIV-infected patients receiving combination antiretroviral therapy: results from the TREAT Asia HIV observational database. Clinical Infectious Diseases 48, 940950.
  • Stringer JS, Zulu I, Levy J et al. (2006) Rapid scale-up of antiretroviral therapy at primary care sites in Zambia. JAMA 296, 782793.
  • The Global Fund to fight AIDS Tuberculosis and Malaria (2008) Annual Report 2008. Available at: http://www.theglobalfund.org/documents/publications/annualreports/2008/Annual Report2008.pdf (accessed on 30 September 2009).
  • Tonwe-Gold B, Ekouevi DK, Amani-Bosse C et al. (2009) Implementing family-focused HIV care and treatment: the first two years’ experience of the MTCT-Plus program in Abidjan, Côte d’Ivoire. Tropical Medicine and International Health 14, 204212.
  • Toure S, Kouadio B, Seyler C et al. (2008) Rapid scaling-up of antiretroviral therapy in 10,000 adults in Cote d’Ivoire: 2-year outcomes and determinants. AIDS 22, 873882.
  • Tsague L, Koulla S, Kenfak A et al. (2008) Determinants of retention in care in an antiretroviral therapy (ART) program in urban Cameroon. The Pan African Medical Journal 1, 12.
  • Weidle PJ, Malamba S, Mwebaze R et al. (2002) Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients’ response, survival, and drug resistance. Lancet 360, 3440.
  • WHO/UNAIDS/UNICEF (2008) Towards universal access. Scaling up priority HIV/AIDS interventions in the health sector. Available at: http://www.who.int/hiv/pub/towards_universal_access_report_2008.pdf (accessed on 30 September 2009)
  • Yu JK, Chen SC, Wang KY et al. (2007) True outcomes for patients on antiretroviral therapy who are “lost to follow-up” in Malawi. Bulletin of the World Health Organization 85, 550554.